<?xml version="1.0" encoding="UTF-8"?>
<ref id="B55">
 <label>55</label>
 <element-citation publication-type="journal">
  <person-group person-group-type="author">
   <name>
    <surname>Wang</surname>
    <given-names>Y. Q.</given-names>
   </name>
   <name>
    <surname>Wang</surname>
    <given-names>P. Y.</given-names>
   </name>
   <name>
    <surname>Wang</surname>
    <given-names>Y. T.</given-names>
   </name>
   <name>
    <surname>Yang</surname>
    <given-names>G. F.</given-names>
   </name>
   <name>
    <surname>Zhang</surname>
    <given-names>A.</given-names>
   </name>
   <name>
    <surname>Miao</surname>
    <given-names>Z. H.</given-names>
   </name>
  </person-group>
  <article-title>An update on poly(ADP-ribose)polymerase-1 (PARP-1) inhibitors: opportunities and challenges in cancer therapy</article-title>
  <source>
   <italic toggle="yes">Journal of Medicinal Chemistry</italic>
  </source>
  <year>2016</year>
  <volume>59</volume>
  <issue>21</issue>
  <fpage>9575</fpage>
  <lpage>9598</lpage>
  <pub-id pub-id-type="doi">10.1021/acs.jmedchem.6b00055</pub-id>
  <pub-id pub-id-type="other">2-s2.0-84994908887</pub-id>
  <?supplied-pmid 27416328?>
  <pub-id pub-id-type="pmid">27416328</pub-id>
 </element-citation>
</ref>
